2024年6月最新影响因子数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎
反馈给我们。基本信息 | 登录收藏 | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | Anti-Cancer Agents in Medicinal Chemistry ANTI-CANCER AGENT ME (此期刊被最新的JCR期刊SCIE收录) LetPub评分 5.3
50人评分
我要评分
声誉 6.4 影响力 4.1 速度 7.0 | |||||||||||||||||||||||||||||||
期刊ISSN | 1871-5206 | 微信扫码收藏此期刊 | ||||||||||||||||||||||||||||||
E-ISSN | 1875-5992 | |||||||||||||||||||||||||||||||
2023-2024最新影响因子 (数据来源于搜索引擎) | 2.6 点击查看影响因子趋势图 | |||||||||||||||||||||||||||||||
实时影响因子 | 截止2024年10月29日:2.24 | |||||||||||||||||||||||||||||||
2023-2024自引率 | 3.80%点击查看自引率趋势图 | |||||||||||||||||||||||||||||||
五年影响因子 | 2.5 | |||||||||||||||||||||||||||||||
JCI期刊引文指标 | 0.59 | |||||||||||||||||||||||||||||||
h-index | 82 | |||||||||||||||||||||||||||||||
CiteScore ( 2024年最新版) |
| |||||||||||||||||||||||||||||||
期刊简介 |
| |||||||||||||||||||||||||||||||
期刊官方网站 | http://benthamscience.com/cmcaca/ | |||||||||||||||||||||||||||||||
期刊投稿网址 | http://benthamscience.com/cmcaca/MSandI.htm | |||||||||||||||||||||||||||||||
期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足Anti-Cancer Agents in Medicinal Chemistry的语言要求,还能让Anti-Cancer Agents in Medicinal Chemistry编辑和审稿人得到更好的审稿体验,让稿件最大限度地被Anti-Cancer Agents in Medicinal Chemistry编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢 。
提交文稿 | |||||||||||||||||||||||||||||||
是否OA开放访问 | No | |||||||||||||||||||||||||||||||
通讯方式 | BENTHAM SCIENCE PUBL LTD, EXECUTIVE STE Y26, PO BOX 7917, SAIF ZONE, SHARJAH, U ARAB EMIRATES, 1200 BR | |||||||||||||||||||||||||||||||
出版商 | Bentham Science Publishers B.V. | |||||||||||||||||||||||||||||||
涉及的研究方向 | ONCOLOGY-CHEMISTRY, MEDICINAL | |||||||||||||||||||||||||||||||
出版国家或地区 | U ARAB EMIRATES | |||||||||||||||||||||||||||||||
出版语言 | English | |||||||||||||||||||||||||||||||
出版周期 | Monthly | |||||||||||||||||||||||||||||||
出版年份 | 2006 | |||||||||||||||||||||||||||||||
年文章数 | 201点击查看年文章数趋势图 | |||||||||||||||||||||||||||||||
Gold OA文章占比 | 1.69% | |||||||||||||||||||||||||||||||
研究类文章占比: 文章 ÷(文章 + 综述) | 68.16% | |||||||||||||||||||||||||||||||
WOS期刊SCI分区 ( 2023-2024年最新版) | WOS分区等级:3区
| |||||||||||||||||||||||||||||||
中国科学院《国际期刊预警 名单(试行)》名单 | 2024年02月发布的2024版:不在预警名单中 2023年01月发布的2023版:不在预警名单中 2021年12月发布的2021版:不在预警名单中 2020年12月发布的2020版:不在预警名单中 | |||||||||||||||||||||||||||||||
中国科学院SCI期刊分区 ( 2023年12月最新升级版) | 点击查看中国科学院SCI期刊分区趋势图
| |||||||||||||||||||||||||||||||
中国科学院SCI期刊分区 ( 2022年12月升级版) |
| |||||||||||||||||||||||||||||||
中国科学院SCI期刊分区 ( 2021年12月旧的升级版) |
| |||||||||||||||||||||||||||||||
SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE) Scopus (CiteScore) | |||||||||||||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1871-5206%5BISSN%5D | |||||||||||||||||||||||||||||||
平均审稿速度 | 网友分享经验: 偏慢,4-8周 | |||||||||||||||||||||||||||||||
平均录用比例 | 网友分享经验: 较易 | |||||||||||||||||||||||||||||||
LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)后论文在Anti-Cancer Agents in Medicinal Chemistry顺利发表。
快看看作者怎么说吧:服务好评 论文致谢 | |||||||||||||||||||||||||||||||
期刊常用信息链接 |
|
|
中国学者近期发表的论文 | |
1. | Alantolactone Inhibits Melanoma Cell Culture Viability and Migration and Promotes Apoptosis by Inhibiting Wnt/beta-Catenin Signaling Author: Zhang, Lingzhao; Chen, Jiayi; Chen, Yangmei; Zou, Daopei; Pu, Yihuan; Wei, Mengqi; Huang, Yanran; Li, Yuxin; Huang, Qing; Chen, Jin Journal: ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY. 2023; Vol. 23, Issue 1, pp. 94-104. DOI: 10.2174/1871520622666220519100054 PubMed DOI |
2. | Novel Potent EGFR-JAK3 Dual-Target Inhibitor that Overcomes KRAS Mutation Resistance in Colorectal Cancer Author: Wu, Tingyu; Yu, Jiawen; Wang, Changyuan; Jin, Yue; Zheng, Xu; Chen, Lixue; Ma, Xiaodong; Sun, Xiuli Journal: ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY. 2023; Vol. 23, Issue 4, pp. 440-449. DOI: 10.2174/1871520622666220609112816 PubMed DOI |
3. | Advances in the Study of Hexokinase 2 (HK2) Inhibitors Author: Wang, Shaopei; Zhuang, Yan; Xu, Jindan; Tong, Yan; Li, Xiaofei; Dong, Chunhong Journal: ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY. 2023; Vol. 23, Issue 7, pp. 736-746. DOI: 10.2174/1871520623666221020092423 PubMed DOI |
4. | Molecular Mechanisms of Sanguinarine in Cancer Prevention and Treatment Author: Ullah, Asmat; Ullah, Najeeb; Nawaz, Touseef; Aziz, Tariq Journal: ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY. 2023; Vol. 23, Issue 7, pp. 765-778. DOI: 10.2174/1871520622666220831124321 PubMed DOI |
5. | The Synergistic Anti-colon Cancer Effect of Aurora A Inhibitors and AKT Inhibitors Through PI3K/AKT Pathway Author: Sun, Cheng; Qu, Zhen; Liu, Weilin; Qiu, Zhigang; Lu, Yanfeng; Sun, Zhenqing Journal: ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY. 2023; Vol. 23, Issue 1, pp. 87-93. DOI: 10.2174/1871520622666220422133537 PubMed DOI |
6. | Ganoderic Acid A Enhances Tumor Suppression Function of Oxaliplatin via Inducing the Cytotoxicity of T Cells Author: Song, Zhichao; Wang, Chunhui; Ding, Fei; Zou, Hao; Liu, Chengkui Journal: ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY. 2023; Vol. 23, Issue 7, pp. 832-838. DOI: 10.2174/1871520623666221103110934 PubMed DOI |
7. | Isoproterenol-induced Upregulation of HPSE Accelerates Triple-negative Breast Cancer Cell Proliferation and Migration through Enhancing the Transcriptional Activity of HIF-1 alpha Author: Qiu, Jian; Shen, Zhongyi; Jiang, Guoqin; Ni, Qichao Journal: ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY. 2023; Vol. 23, Issue 4, pp. 470-477. DOI: 10.2174/1871520622666220817125817 PubMed DOI |
8. | Tanshinone IIA Alleviates the Biological Characteristics of Colorectal Cancer via Activating the ROS/JNK Signaling Pathway Author: Qian, Jun; Cao, Yi; Zhang, Junfeng; Li, Lingchang; Wu, Juan; Yu, Jialin; Huo, Jiege Journal: ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY. 2023; Vol. 23, Issue 2, pp. 227-236. DOI: 10.2174/1871520622666220421093430 PubMed DOI |
9. | Combined Effects of Programmed Cell Death-1 Blockade and Endostar on Brain Metastases of Lung Cancer Author: Qi, Xuejiao; Zhao, Yinlong; Yang, Song; Sun, YuMeng; Liu, Honglei; Liu, Pengyu; Feng, Shiyao; Tui, Hongbo; Yuan, Zheng; Yang, Jiankai; Bu, Hui Journal: ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY. 2023; Vol. 23, Issue 6, pp. 709-716. DOI: 10.2174/1871520622666220827125929 PubMed DOI |
10. | New neo-Clerodane Diterpenoids Isolated from Ajuga decumbens Thunb., Planted at Pingtan Island of Fujian Province with the Potent Anticancer Activity Author: Olatunde, Olagoke Zacchaeus; Yong, Jianping; Lu, Canzhong Journal: ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY. 2023; Vol. 23, Issue 2, pp. 237-244. DOI: 10.2174/1871520622666220620151225 PubMed DOI |
|
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2024 中国: LetPub上海 网站备案号:沪ICP备10217908号-1 沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)
增值电信业务经营许可证:沪B2-20211595 网络文化经营许可证:沪网文[2023]2004-152号
礼翰商务信息咨询(上海)有限公司 办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室